Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown Significance
HLA · 2026
DOI: 10.1111/tan.70589 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift HLA, 2026. Verfasst von Shahram Arsang-Jang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Genetic Predisposition to Disease, Monoclonal Gammopathy of Undetermined Significance, Major Histocompatibility Complex. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leukaemia and Lymphoma Society, NHLBI NIH HHS, Medical College of Wisconsin.
Abstract (Originalsprache)
Genome‐wide association studies have linked major histocompatibility complex (MHC) region loci to immune‐related diseases, but their role in multiple myeloma (MM) progression from monoclonal gammopathy of undetermined significance (MGUS) remains unclear. This case–control study included 238 individuals with MGUS (> 5 years follow‐up without MM progression) and 618 MM patients from MCW Froedtert Hospital (2011–2020). Using multivariable logistic regression, Omnibus test and conditional haplotype tests, we identified HLA alleles and amino acid positions associated with MM risk compared to MGUS. The HLA‐A*30:01 (OR pooled = 7.90, 95% CI = 3.05–20.00, P pooled = 2.04 × 10 −5 ), HLA‐B*08:01 (OR pooled = 0.40, 95% CI = 0.28–0.58, P pooled = 1.16 × 10 −6 ) and HLA‐DRB1*15:03 (OR pooled = 0.26, 95% CI = 0.16–0.43, P pooled 1.14 × 10 −7 ) were consistently identified to be associated with the risk of MM when compared with MGUS across the four imputed datasets. Additional associations were observed for HLA‐A*30:02 (OR pooled = 0.45, 95% CI = 0.28–0.72, P pooled = 8.66 × 10 −4 ) and HLA‐C*07:01 (OR pooled = 0.62, 95% CI = 0.49–0.79, P pooled = 6.49 × 10 −5 ) in two or three imputation datasets. Omnibus test identified three amino acid positions associated with MM risk: HLA‐A position 152 ( P Omnibus = 0.005), HLA‐B position 9 ( P omnibus = 0.034) and HLA‐C position 66 ( P omnibus = 0.011). These findings suggest an important role of HLA class I and II molecules in the genetic susceptibility of MM compared with MGUS, suggesting alterations in peptide‐binding capabilities may impair immune recognition of malignant cells. Further studies are needed to validate our findings and elucidate the biological mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Division of Hematology and Oncology, Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA.
- Jiangsu Cancer Centre, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, USA.
- Linda T. And John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
ORCID-Profile: Bicky Thapa, Anita D'Souza, Binod Dhakal
Förderung
- Leukaemia and Lymphoma Society
- NHLBI NIH HHS
- Medical College of Wisconsin
- NIH HHS
- Medical College of Wisconsin Cancer Center
- Riney Family Multiple Myeloma Research Initiative
- NCATS NIH HHS
- Drive Fore A Cure Foundation
Zitieren
APA
Arsang-Jang, S., Massat, B., Pareek, G., Han, J., Thapa, B., Patek, V., Nader, Z., Auer, P. L., Zimmerman, M. T., Urrutia, R., Hari, P., D'Souza, A., Dhakal, B., Janz, S., & Dong, J. (2026). Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown Significance. HLA. https://doi.org/10.1111/tan.70589
Vancouver
Arsang-Jang S, Massat B, Pareek G, Han J, Thapa B, Patek V, et al. Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown Significance. HLA. 2026. doi:10.1111/tan.70589
BibTeX
@article{ArsangJang2026,
author = {Arsang-Jang, Shahram and Massat, Ben and Pareek, Gokul and Han, Jing and Thapa, Bicky and Patek, Victoria and Nader, Zeina and Auer, Paul L and Zimmerman, Michael T and Urrutia, Raul and Hari, Parameswaran and D'Souza, Anita and Dhakal, Binod and Janz, Siegfried and Dong, Jing},
title = {Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown Significance},
journal = {HLA},
year = {2026},
doi = {10.1111/tan.70589}
}
EUVIMED